Image-guided radiation therapy developer ViewRay said that its MRIdian MRI-guided radiation therapy system will be the subject of 26 clinical presentations and posters at the European Society for Radiotherapy and Oncology (ESTRO) annual meeting in Milan on 26-30 April.
ViewRay said the presentations and posters will report on clinical experience, patient outcomes, and response assessment and prediction, as well as physics topics, commissioning, and quality assurance. Covering a wide range of clinical applications, the abstracts include clinical data from more than 150 patients, according to the firm. In addition, a significant number of the talks will highlight MRIdian's adaptive therapy capabilities, ViewRay said.
